These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study. Mills A; Crofoot G; McDonald C; Shalit P; Flamm JA; Gathe J; Scribner A; Shamblaw D; Saag M; Cao H; Martin H; Das M; Thomas A; Liu HC; Yan M; Callebaut C; Custodio J; Cheng A; McCallister S J Acquir Immune Defic Syndr; 2015 Aug; 69(4):439-45. PubMed ID: 25867913 [TBL] [Abstract][Full Text] [Related]
10. The Lymphoid Tissue Pharmacokinetics of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide in HIV-Infected Persons. Fletcher CV; Podany AT; Thorkelson A; Winchester LC; Mykris T; Anderson J; Jorstad S; Baker JV; Schacker TW Clin Pharmacol Ther; 2020 Nov; 108(5):971-975. PubMed ID: 32385902 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial. Post FA; Yazdanpanah Y; Schembri G; Lazzarin A; Reynes J; Maggiolo F; Yan M; Abram ME; Tran-Muchowski C; Cheng A; Rhee MS HIV Clin Trials; 2017 May; 18(3):135-140. PubMed ID: 28303753 [TBL] [Abstract][Full Text] [Related]
12. Tenofovir alafenamide (TAF) does not deplete mitochondrial DNA in human T-cell lines at intracellular concentrations exceeding clinically relevant drug exposures. Stray KM; Park Y; Babusis D; Callebaut C; Cihlar T; Ray AS; Perron M Antiviral Res; 2017 Apr; 140():116-120. PubMed ID: 28131805 [TBL] [Abstract][Full Text] [Related]
13. Renal function change after switching tenofovir disoproxil fumarate for tenofovir alafenamide in the HIV-positive patients of a metropolitan sexual health service. Turner D; Drak D; O'Connor CC; Templeton DJ; Gracey DM AIDS Res Ther; 2019 Dec; 16(1):40. PubMed ID: 31810490 [TBL] [Abstract][Full Text] [Related]
14. Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults. Ruane PJ; DeJesus E; Berger D; Markowitz M; Bredeek UF; Callebaut C; Zhong L; Ramanathan S; Rhee MS; Fordyce MW; Yale K J Acquir Immune Defic Syndr; 2013 Aug; 63(4):449-55. PubMed ID: 23807155 [TBL] [Abstract][Full Text] [Related]
15. Incidence of Acute Kidney Injury in Patients Coinfected with HIV and Hepatitis C Virus Receiving Tenofovir Disoproxil Fumarate and Ledipasvir/Sofosbuvir in a Real-World, Urban, Ryan White Clinic. Michal JL; Rab S; Patel M; Kyle AW; Miller LS; Easley KA; Kalapila AG AIDS Res Hum Retroviruses; 2018 Aug; 34(8):690-698. PubMed ID: 29766745 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects with Severe Renal Impairment. Custodio JM; Fordyce M; Garner W; Vimal M; Ling KH; Kearney BP; Ramanathan S Antimicrob Agents Chemother; 2016 Sep; 60(9):5135-40. PubMed ID: 27216057 [TBL] [Abstract][Full Text] [Related]
17. Tenofovir alafenamide vs. tenofovir disoproxil fumarate: an updated meta-analysis of 14 894 patients across 14 trials. Pilkington V; Hughes SL; Pepperrell T; McCann K; Gotham D; Pozniak AL; Hill A AIDS; 2020 Dec; 34(15):2259-2268. PubMed ID: 33048869 [TBL] [Abstract][Full Text] [Related]
18. Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial. Thurman AR; Schwartz JL; Cottrell ML; Brache V; Chen BA; Cochón L; Ju S; McGowan I; Rooney JF; McCallister S; Doncel GF EClinicalMedicine; 2021 Jun; 36():100893. PubMed ID: 34041459 [TBL] [Abstract][Full Text] [Related]
19. Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate. Hermansson L; Yilmaz A; Price RW; Nilsson S; McCallister S; Makadzange T; Das M; Zetterberg H; Blennow K; Gisslen M PLoS One; 2019; 14(12):e0226276. PubMed ID: 31826005 [TBL] [Abstract][Full Text] [Related]
20. Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog-Associated Mutations and M184V. Margot N; Ram R; Abram M; Haubrich R; Callebaut C Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]